How many patents does
Intercell have?
patents
462
families
57
granted
117
applications
345
EP
127
US
122
CN
29
WO
25
JP
18
KR
4
GB
4
RoW
133
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Intercell
Top ten assignees appearing on patents
2009 - 2018
| intercell | 343 |
| valneva austria | 80 |
| intercell usa | 24 |
| intercell austria | 12 |
| intercell biomedizinische forschun… 🛈 | 8 |
| cytos biotechnology | 3 |
| intercell ag, wien | 2 |
| novartis | 2 |
| intersell | 1 |
| elatos | 1 |
2009
| intercell | 59 |
| cytos biotechnology | 1 |
2018
| valneva austria | 12 |
Intercell
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof | 31 | 2010 |
| streptococcus pyogenes antigens | 27 | 2003 |
| a method for identification, isolation and production of antigens to a specific pathogen | 26 | 2001 |
| aluminium compounds for use in therapeutics and vaccines | 20 | 2011 |
| s. pneumoniae antigens | 20 | 2003 |
| small streptococcus pyogenes antigens and their use | 19 | 2006 |
| improved vaccines | 18 | 2003 |
| streptococcus agalactiae antigens i + ii | 17 | 2003 |
| protective proteins of s. agalactiae, combinations thereof and methods of using the same | 17 | 2007 |
| immunostimulatory oligodeoxynucleotides | 16 | 2000 |